Screening Tool Can Streamline Palliative Care Consults in the ICU
By Lori Solomon HealthDay Reporter
WEDNESDAY, April 3, 2024 -- Integrating a simple screening tool upon intensive care unit (ICU) admission can streamline requests for palliative care consultations, according to a study published online April 1 in Critical Care Nurse.
Traci N. Phillips, D.N.P., from Mercy Health Anderson Hospital in Cincinnati, and colleagues created a palliative care screening tool with clinical indicators for nurses to use upon patient admission to the ICU. The analysis included 267 patients.
The researchers reported that 22 percent of patients had positive screening tool results compared with 11.6 percent identified with the traditional consultative method. Patients identified for referral without use of the screening tool were hospitalized a mean of six days until the consultation was requested.
"The screening tool was designed to be completed on admission by the nursing staff and provides the ability to directly refer patients with positive screening tool results for formal palliative care consultation," the authors write. "Providing the ICU staff the autonomy to consult palliative care services by using an evidence-based tool can improve the efficiency of appropriate consultations while providing opportunities for advance care planning discussions and increasing patient access to palliative care services before discharge."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted April 2024
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.